Greta Van Slyke
Overview
Explore the profile of Greta Van Slyke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berman K, Van Slyke G, Novak H, Rock J, Bievenue R, Damjanovic A, et al.
Microbiol Spectr
. 2024 Oct;
:e0084624.
PMID: 39470282
In the earliest days of the COVID-19 pandemic, the collection of dried blood spots (DBS) enabled public health laboratories to undertake population-scale seroprevalence studies used to estimate rates of SARS-CoV-2...
2.
Berman K, Van Slyke G, Novak H, Rock J, Bievenue R, Damjanovic A, et al.
bioRxiv
. 2024 Apr;
PMID: 38562708
Background: In the earliest days of COVID-19 pandemic, the collection of dried blood spots (DBS) enabled public health laboratories to undertake population-scale seroprevalence studies to estimate rates of SARS-CoV-2 exposure....
3.
Bedard D, Van Slyke G, Nubel U, Bateson M, Brumfield S, An Y, et al.
Microorganisms
. 2023 Dec;
11(12).
PMID: 38138064
Three strains of thermophilic green sulfur bacteria (GSB) are known; all are from microbial mats in hot springs in Rotorua, New Zealand (NZ) and belong to the species . Here,...
4.
Kumru O, Bajoria S, Kaur K, Hickey J, Van Slyke G, Doering J, et al.
Hum Vaccin Immunother
. 2023 Nov;
19(2):2264594.
PMID: 37932241
Second-generation COVID-19 vaccines with improved immunogenicity (e.g., breadth, duration) and availability (e.g., lower costs, refrigerator stable) are needed to enhance global coverage. In this work, we formulated a clinical-stage SARS-CoV-2...
5.
Bajoria S, Kumru O, Doering J, Berman K, Van Slyke G, Prigodich A, et al.
Vaccines (Basel)
. 2023 Jun;
11(6).
PMID: 37376419
Aluminum-salt vaccine adjuvants (alum) are commercially available as micron-sized particles with varying chemical composition and crystallinity. There are reports of enhanced adjuvanticity when the alum's particle size is reduced to...
6.
Roy C, Ehrbar D, Van Slyke G, Doering J, Didier P, Doyle-Meyers L, et al.
NPJ Vaccines
. 2022 Dec;
7(1):164.
PMID: 36526642
Inhalation of the biothreat agent, ricin toxin (RT), provokes a localized inflammatory response associated with pulmonary congestion, edema, neutrophil infiltration, and severe acute respiratory distress. The extreme toxicity of RT...
7.
Movahed E, Vance D, Ehrbar D, Van Slyke G, Yates J, Kullas K, et al.
mSphere
. 2022 Jul;
7(4):e0025222.
PMID: 35876530
Decorin binding protein A (DbpA) is a surface adhesin of Borrelia burgdorferi, the causative agent of Lyme disease. While DbpA is one of the most immunogenic of B. burgdorferi's nearly...
8.
Bajoria S, Kaur K, Kumru O, Van Slyke G, Doering J, Novak H, et al.
Hum Vaccin Immunother
. 2022 Jun;
18(5):2079346.
PMID: 35666264
Low-cost, refrigerator-stable COVID-19 vaccines will facilitate global access and improve vaccine coverage in low- and middle-income countries. To this end, subunit-based approaches targeting the receptor-binding domain (RBD) of SARS-CoV-2 Spike...
9.
Doering J, Van Slyke G, Donini O, Mantis N
Methods Mol Biol
. 2021 Dec;
2410:693-705.
PMID: 34914076
The issues of vaccine potency and stability constitute formidable challenges associated with the development and readiness of vaccines for biodefense. In most instances, the vaccines will be stockpiled (at considerable...
10.
Nguyen T, Richards A, Neupane D, Feathers J, Yang Y, Sim J, et al.
Cell Rep
. 2021 Sep;
36(10):109654.
PMID: 34496256
Many bacterial pathogens secrete AB toxins comprising two functionally distinct yet complementary "A" and "B" subunits to benefit the pathogens during infection. The lectin-like pentameric B subunits recognize specific sets...